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J PThe majority of adults in the U.S. can be classiﬁed as overweight or obese (68%), putting them at risk
for Type 2 diabetes, cardiovascular diseases, and other adverse health outcomes. The U.S. Preventive
Services Task Force recommends that providers offer or refer obese adults to intensive, multi-
component lifestyle interventions. However, there is a critical need for interventions that have been
shown to be pragmatic and effective among diverse populations, scalable across different clinical
settings and systems, and sustainable over time. The Pragmatic–Explanatory Continuum Indicator
Summary (PRECIS) tool can be used to assess the degree to which trials of behavioral lifestyle
interventions provide evidence to support this need. We used our recently completed trial,
Evaluation of Lifestyle Interventions to Treat Elevated Cardiometabolic Risk in Primary Care
(E-LITE), as a case study and assessed the domains of PRECIS to explore the degree to which we felt
it achieved its intended pragmatic design (completed in December 2014). Overall, the systematic
assessment using the PRECIS tool revealed that the E-LITE trial design was very pragmatic in nature.
Its results and the subsequent adoption of the intervention into actual practice also suggest high
potential for implementation of primary care interventions.
(Am J Prev Med 2015;49(3S2):S208–S214) & 2015 American Journal of Preventive Medicine. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).IntroductionThe majority of adults in the U.S. can be classiﬁedas overweight (33%) or obese (35%),1 puttingthem at risk for Type 2 diabetes, cardiovascular
diseases, various cancers, and other physical and mental
health problems,2,3 which have high personal, societal,
and healthcare costs.4 The magnitude and breadth of this
crisis call for multisectoral approaches for obesity pre-
vention and treatment.
Given their unique position as a usual point of
contact between patients and the healthcare system,
primary care staff and providers hold high potential for
screening, activating, and engaging the large portion of
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is an open access article under the CC BY-NCmanagement program.5,6 Behavioral lifestyle interven-
tions that use evidence-based strategies to promote
healthy diet and moderate physical activity have been
shown to be effective for weight loss and cardiometa-
bolic risk reduction among high-risk individuals.7,8 As a
result, the U.S. Preventive Services Task Force
(USPSTF) recommends that providers offer or refer
obese adults to intensive, multicomponent lifestyle
interventions.7,8 In response to the Affordable Care
Act’s preventive services coverage mandate,9 the Cen-
ters for Medicare and Medicaid Services reimburses
intensive behavioral therapy for obesity when it is
furnished by qualiﬁed providers during brief (15-
minute) visits in primary care settings.10 However,
there have been numerous barriers to successfully
operationalizing these policies.11 An important need
exists for interventions that have been shown to be
pragmatic and effective among diverse populations,
scalable across different clinical settings and systems,
and sustainable over time. The Pragmatic–Explanatory
Continuum Indicator Summary (PRECIS) tool can be
used to assess the degree to which trials of behavioralJournal of Preventive Medicine  Published by Elsevier Inc. This
-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Rosas et al / Am J Prev Medlifestyle interventions provide evidence to support this
research need.12 The tool acknowledges the continuum
between trials that are strictly explanatory (efﬁcacy
trials) and those that are highly pragmatic (effectiveness
trials). We used our recently completed trial, Evaluation
of Lifestyle Interventions to Treat Elevated Cardiome-
tabolic Risk in Primary Care (E-LITE), as a case study
and assessed the domains of PRECIS to explore the
degree to which we felt it achieved its intended
pragmatic design (completed in December 2014). We
also discuss the implementation of our research ﬁndings
within the healthcare system to demonstrate the prag-
matic nature of the trial. Although the PRECIS tool is
ideally utilized during the planning stages of a trial, it is
also useful as a heuristic to inform implementation and
dissemination of study results as well as informative for
identifying future research goals in the area of primary
care–based lifestyle interventions.12
The E-LITE study, described in detail elsewhere,13,14
was a three-arm, primary care–based RCT designed to
evaluate the effectiveness and implementation potential
of two adapted behavioral weight loss interventions for
15 months compared with usual care among overweight
or obese adults with prediabetes, metabolic syndrome,
or both (conducted from 2009 to 2013). Participants in
both intervention groups received an adapted, 12-
session lifestyle intervention curriculum, Group Life-
style Balance (GLB)™, which was developed by inves-
tigators at the University of Pittsburgh after conclusion
of the Diabetes Prevention Program (DPP) trial.15
Both groups were trained to use the American Heart
Association’s (AHA’s) free, secure Heart360 web portal
for weight and physical activity goal setting and
self-monitoring and were given a weight scale and
pedometer.
Participants randomized to the coach-led arm partici-
pated in group sessions in the clinic led by a lifestyle
coach, whereas those in the self-directed arm engaged in
the intervention through accessing a DVD at home. The
intensive phase for both interventions was followed by a
12-month maintenance phase (via secure messaging for
ongoing lifestyle coaching within an electronic health
record [EHR] system and the AHA Heart360 website).
Both intervention groups achieved statistically greater
reductions in BMI, accompanied by improvements in
waist circumference and fasting plasma glucose, as
compared with usual care.14 At 15 months, the mean
(SE) change in weight from baseline was –6.3 (0.9) kg in
the coach-led intervention; –4.5 (0.9) kg in the self-
directed intervention; and –2.4 (0.9) in the usual care
group.14 The E-LITE trial was included as key evidence in
the 2014 USPSTF guidelines for behavioral counseling in
primary care.16September 2015PRECIS Domains and the E-LITE Trial
The PRECIS tool utilizes a sum (range, 0–50) of ratings
(1¼most explanatory; 5¼most pragmatic) on each of ten
domains described in Table 1.17 We used E-LITE as a
case study to illustrate the degree to which the design was
explanatory or pragmatic in nature. To summarize the
research teams’ perspectives, each author independently
assessed the ten domains and provided a whole number
score between 1 and 5 (1¼extremely explanatory; 2¼very
explanatory; 3¼explanatory/pragmatic nexus; 4¼very
pragmatic; 5¼extremely pragmatic). To create a visual
representation of the explanatory versus pragmatic
nature of the trial, known as a pragmascope (Figure 1),
an approach by Tosh et al.17 was adapted. The median of
each author’s score was plotted on the pragmascope.
Subsequently, the authors discussed each domain and
came to a consensus on a summary rating and narrative
description for each domain (Table 1).
In general, the E-LITE trial was rated as very prag-
matic or extremely pragmatic across the majority of
domains (80%), with a total score of 40.5 out of 50
(Figure 1). Domains noted to be extremely pragmatic
included the comparison group of usual care, the
practitioner expertise for the usual care group, and the
analytic approach based on the intent-to-treat principle
and including all participants regardless of level of
adherence. The follow-up intensity was rated as very
explanatory given the protocol that included three in-
person visits conducted by trained research assistants
blinded to treatment assignment. Overall, the systematic
assessment using the PRECIS tool revealed that the E-
LITE trial design was very pragmatic in nature, reﬂecting
the initial study aims. Without conﬁrmation by a
sufﬁcient sample of external scientists, we cannot for-
mally test the hypothesis that the E-LITE study was
pragmatic in nature. However, our exploration can serve
as a case study and example exercise that can be used in
the planning stages for similar studies.
2015;49(3S2):S208–S214 S209Potential for Dissemination and
Implementation in Primary Care Settings
Results from the trial and a subsequent evaluation of its
potential for widespread adoption18 contributed to the
implementation of a coach-led intervention modeled
after the E-LITE intervention within the large, multi-
specialty outpatient healthcare system in Northern Cal-
ifornia where the trial was conducted. Since 2011, the
healthcare system has launched a gradual rollout at ﬁve
of its more than 40 clinic sites. The service is intended for
overweight or obese adult patients with high cardiome-
tabolic risk as identiﬁed by provider or self-referral.
Table 1. Assessment of PRECIS Domains for the E-LITE Trial
PRECIS Domaina E-LITE description Ratingb
Participants
Eligibility criteria
Extremely explanatory: Restrictive
inclusion criteria, exclusion criteria that
make the study population less reﬂective
of the target population
Extremely pragmatic: Open to entire
target population, few if any exclusions
The trial enrolled participants from a single
primary care clinic within the Silicon Valley
(Los Altos, California) that is part of a large
multispecialty group. Participants were
eligible to participate if they were 18 years
or older, had a BMI greater than 25, and
had pre-diabetes (deﬁned by impaired
fasting plasma glucose of 5.6–6.9 mmol/L)
or metabolic syndrome.
Very pragmatic: The study included all
patients in the target population with
limited exclusions related to research
requirements only. The study was only
conducted in one geographic region, which
precluded the designation of extremely
pragmatic.
Interventions and expertise
Experimental intervention ﬂexibility
Extremely explanatory: Rigid intervention
protocol that does not allow for
adaptation to variation in real life
Extremely pragmatic: Creativity allowed
and encouraged to adapt to variation in
real life settings
There were two interventions being tested
in this trial. Participants in both intervention
groups completed a 3-month intensive
intervention phase and a 12-month
maintenance phase. Both groups were
trained to use the AHA free Heart360 Web
portal for weight and physical activity goal
setting and self-monitoring and were given
a weight scale and pedometer.
Self-directed: Curriculum was delivered via
home-based DVD. We made no
modiﬁcations to the GLB DVD. Via secure e-
mail embedded in the EHR, the Lifestyle
Coach sent standardized biweekly
reminder messages about self-monitoring
to self-directed intervention participants
throughout the intensive and maintenance
phase and standardized motivational
messages to participants during the
maintenance phase. The Lifestyle Coach
also answered questions and responded to
messages.
Coach-led: The curriculum was delivered
face-to-face in 12-weekly classes. In
addition to receiving GLB intervention
materials, coach-led intervention
participants had food tastings at check-in
and 30–45 minutes of guided physical
activity at the end of each weekly class.
Participants received the same
standardized messages as in the self-
directed as well as personalized messages
on at least a monthly basis that provided
progress feedback and lifestyle coaching
based on their Heart360 self-monitoring
records.
Very pragmatic: There were two
interventions tested:
Self-directed: The self-directed nature of
this intervention allows for a high level of
individual variation and adaptation.
Coach-led: The coach-led intervention
allows for signiﬁcant individual tailoring
and adaptation to real-life circumstances.
Attendance at the group sessions is
monitored and encouraged, which makes it
less pragmatic than the self-directed
approach.
Practitioner expertise for experimental
intervention
Extremely explanatory: Delivered by
highly trained staff that are outside
experts
Extremely pragmatic: Delivered by staff
regularly involved in patient care
The E-LITE Lifestyle Coach, a registered
dietitian certiﬁed to deliver the GLB
program, and a contracted ﬁtness
instructor jointly taught all the classes at
the participating clinic. The dietician was
part of the primary care workforce at the
setting prior to joining the study. Both the
dietician and the ﬁtness instructor had no
prior research experience.
Very pragmatic: A central issue for this
domain is the role of a lifestyle coach within
primary care. Although not currently routine
practice in primary care across the U.S.,
lifestyle coaches and health promoters with
some level of training in lifestyle behavior
change are increasingly being incorporated
into the primary care setting.
Practitioner expertise for comparison
intervention
Extremely explanatory: Delivered by
highly trained staff not involved in
routine care
The comparator of usual care in the E-LITE
trial was provided by existing primary care
staff and providers.
Extremely pragmatic: The usual care
comparison did not involve any additional
training or resources.
(continued on next page)
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Table 1. Assessment of PRECIS Domains for the E-LITE Trial (continued)
PRECIS Domaina E-LITE description Ratingb
Extremely pragmatic: Delivered by staff
regularly involved in patient care
Flexibility of comparison intervention
Extremely explanatory: High divergence
from routine care
Extremely pragmatic: Currently
happening in everyday practice
The interventions were compared to usual
care. The study provided no information
about weight loss or weight-loss goals to
participants in the usual care group.
Extremely pragmatic: The trial design did
not include any additional resources aside
from what is normally available to
participants in usual care.
Follow-up and outcomes
Follow-up intensity
Extremely explanatory: Pre-speciﬁed data
collection visits with incentives for
participation
Extremely pragmatic: Covert
assessments that are part of routine
patient care
In-person data collection visits conducted
by research assistant were scheduled at
baseline, 3, 6, and 15 months. At each time
point, research assistants conducted an
interview and performed anthropometric
and blood pressure measurements using
standard protocols.
Very explanatory: The intensity and
participant burden of the follow-up visits
determined the explanatory nature for this
domain.
Primary trial outcome
Extremely explanatory: Important only to
the researcher, highly complex
measurement that can only be carried
out by specialists
Extremely pragmatic: Patient-centered,
long-term, easy to measure as part of
routine clinical care
The primary outcome of the E-LITE trial was
change in BMI from baseline to 15 months.
Very pragmatic: Weight change was of
primary interest to the participants, making
it very pragmatic. Additionally, BMI can be
easily measured in routine primary care,
furthering the degree to which the outcome
falls on the pragmatic side of the
continuum. Psychosocial outcomes
assessing patient’s overall well-being, such
as a measure of health-related quality of
life, were secondary outcomes.
Compliance/adherence
Participant compliance
Extremely explanatory: Strictly monitored
with participants excluded based on non-
compliance with the intervention
Extremely pragmatic: Non-compliance is
assumed as part of real-world settings;
compliance is not even monitored
The data from this trial were analyzed using
intent to treat and thus recognized that
non-compliance is a reality in routine
primary care. Compliance to participation in
the group sessions for participants
randomized to the coach-led group was
monitored. Similarly, the number of secure
e-mail messages was monitored for both
groups. However, no special strategies
were used to enhance compliance.
Very pragmatic: The analytic design
allowed for real life variation in adherence
to the intervention protocol, making the
trial very pragmatic. Because adherence
was monitored, the trial does not meet
criteria for extremely pragmatic.
Practitioner adherence
Extremely explanatory: Strictly monitored
and continuously addressed throughout
the trial
Extremely pragmatic: Delivery is
assumed to be variable to reﬂect the
diversity of patient needs/scenarios
In the coach-led intervention, the
intervention practitioner followed a set
curriculum for the group sessions. In
addition, by design, practitioners were
encouraged to individually tailor the
strategies using practical and creative
strategies. The ﬁdelity of the intervention
was assessed as part of the trial design.
Very pragmatic: The practitioner
adherence falls on the pragmatic end of the
spectrum. The monitoring of practitioner
adherence prevents a rating of extremely
pragmatic.
Analysis
Extremely explanatory: Data excluded
based on adherence and compliance
Extremely pragmatic: No data are
excluded and subgroup analyses are not
conducted
An intention-to-treat analysis was
conducted with no restrictions, including all
participants regardless of dose of
intervention received.
Extremely pragmatic: The analytic design
followed an extremely pragmatic approach.
aDescription of the domains and deﬁnitions for “extremely explanatory” and “extremely pragmatic” were adapted from Tosh et al.17
bRating system: 1¼extremely explanatory, 2¼very explanatory, 3¼explanatory/pragmatic nexus; 4¼very pragmatic; 5¼extremely pragmatic.
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(79%) of participants have been women in their mid
50s, with an average BMI of 35 and a large proportion
(45%) with a BMI greater than 35. Of those who
participated for at least 3 months (n¼442), 70%September 2015completed at least six, and 40% completed at least ten,
of the 12 weekly group sessions. At 3 months, mean
(SD) weight loss was –3.6 (3.9) kg. For patients who had
data available in the EHR, weight loss was –5.6 (6.3) kg
at 6 months (n¼227) and –4.5 (5.4) kg at 12 months
Figure 1. Pragmascope of PRECIS domains reﬂecting authors’ rating of E-LITE trial.
Rosas et al / Am J Prev Med 2015;49(3S2):S208–S214S212(n¼110). These data have motivated expanded imple-
mentation of the service at the existing and additional
sites with more invested efforts to further improve
session enrollment and attendance.
Although not yet adopted at this same Northern
California organization, the self-directed E-LITE
approach is especially well suited for delivery in diverse
primary care settings given its exportability, low cost, and
convenience for patients. The self-directed approach can
be adopted within existing healthcare infrastructure and
requires modest personnel and other resources to imple-
ment. The GLB DVD is available in both English and
Spanish, making it accessible to a large and at-risk ethnic
minority group. Each session is brief (approximately 20
minutes in length) and patients can view the 12 GLB
sessions on a weekly basis at home. As an alternative to
DVD viewing at home, participants may watch the GLB
DVD through a secure website or potentially at libraries
and community centers. Primary care providers may
directly serve as an educator and distributor of the
program, or may serve in a consultative and supportive
role, referring patients to GLB-trained lifestyle coaches
who can distribute the GLB DVD to patients and
monitor their progress for offering personalized
coaching.Conclusions and Key Recommendations
In summary, the E-LITE trial was designed to offer
evidence of the effectiveness of implementing intensive
lifestyle interventions into routine primary care. The
design successfully reﬂected its pragmatic aims. Its results
and the subsequent adoption of the coach-led interven-
tion into actual practice also suggest high potential for
implementation of primary care interventions based on
the GLB and DPP.
Experience with the E-LITE trial and its implementa-
tion within the healthcare system has prompted several
recommendations for future research to expand scientiﬁc
understanding of pragmatic approaches to behavioral
weight loss treatment in primary care settings:1. Tailored approaches are needed to promote scal-
ability in diverse populations and primary care
settings. The E-LITE trial provided evidence of
effectiveness among a target population of highly
educated, primarily non-Hispanic white men and
women. E-LITE succeeded in recruiting and retaining
a study population of more than half men, far
surpassing the usual proportion of men recruited into
lifestyle intervention trials (0%–20%). Building on thiswww.ajpmonline.org
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Sepsuccess among both genders, future research should
focus on approaches tailored for speciﬁc ethnic groups
as well as diverse settings, such as community health
centers, which are of high importance.19,202. Information technology can be used to increase
reach and effectiveness. Technology enables reaching
patients in settings outside of the healthcare system
and tailoring to patients’ individualized perspectives
and circumstances. E-LITE utilized secure e-mail
messaging embedded in an EHR for lifestyle coaching
and the AHA Heart360 web portal for self-
management. Emerging technologies, such as virtual
lifestyle coaches, online social networks for social
support, mobile phone applications, and novel sensors,
should be rigorously evaluated for potential inclusion in
lifestyle interventions in primary care settings.21,223. Engage multiple sectors to address lifestyle behav-
iors for synergy that promotes sustainable behavior
change. Building upon the success in E-LITE in the
primary care setting, strategies that add linkages to
other potential spheres of inﬂuence on people’s health
behavior such as community-based programs should
be rigorously tested.23,244. Take advantage of teachable moments across the life
course. Using a life course approach, lifestyle inter-
ventions may be most effective if tailored for individ-
uals in speciﬁc time periods of life when they may be
at high risk for obesity or uniquely open to changing
lifestyle behaviors.25,26 Examples of these time periods
may include adolescence/puberty, ﬁrst year of uni-
versity/junior college, ﬁrst job, marriage, pregnancy,
diagnosis of a chronic disease, and retirement.
The E-LITE trial also highlighted several best practices
for researcher and practitioners interested in pragmatic
lifestyle intervention research. First, strong partnerships
and engagement with key stakeholders in primary care
including the administration, staff, providers, and
patients in all phases of the research (e.g., design,
implementation, follow-up) are key to successfully com-
pleting pragmatic trials. Second, transdisciplinary teams
engaged in team science approaches are important for the
design, implementation, and dissemination of pragmatic
lifestyle trials. Importantly, the key stakeholder engage-
ment and multidisciplinary scientiﬁc teams should focus
on issues of scalability across patient groups and settings as
well as sustainability at the patient and setting level. These
best practices, coupled with utilization of the PRECIS
framework, have high potential for evidence that will
promote reducing the burden of obesity in the U.S.
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